The Top Line
By Fierce Life Sciences
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Fierce Life Sciences
Category: Business News
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 28
Reviews: 0
Episodes: 100
Description
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
| Episode | Date |
|---|---|
|
The future of RAS inhibitors
|
Sep 11, 2026 |
|
The people who stayed with the problem
|
Sep 04, 2026 |
|
MrBeast, Snapchat, AI and more: Pharma marketing’s pulse check
|
Aug 28, 2026 |
|
What did we learn from Big Pharma’s Q2 results?
|
Aug 21, 2026 |
|
How consumerization is reshaping pharma marketing (Sponsored)
|
Aug 17, 2026 |
|
A genomics library for the AI era
|
Aug 14, 2026 |
|
The next frontier in patient support: Connected data, AI and personalized engagement (Sponsored)
|
Aug 10, 2026 |
|
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
|
Aug 07, 2026 |
|
Inside Noble’s connected approach to patient support (Sponsored)
|
Aug 03, 2026 |
|
Psychedelics, peptides and GLP-1s
|
Jul 31, 2026 |
|
GSK’s first lung cancer approval, a new IPO path and more
|
Jul 24, 2026 |
|
Why modern clinical trials need a finance-first strategy (Sponsored)
|
Jul 20, 2026 |
|
5 emerging biotech hubs
|
Jul 17, 2026 |
|
Operating at the speed of science: The new medical affairs playbook (Sponsored)
|
Jul 14, 2026 |
|
Decision readiness is the next AI advantage (Sponsored)
|
Jul 13, 2026 |
|
A $10B deal, China trial scrutiny and highlights from ADA 2026
|
Jul 10, 2026 |
|
The deal before the deal
|
Jun 26, 2026 |
|
FDA Breakthrough Therapy and RMAT: Strategic Decisions That Can Accelerate Oncology Development (Sponsored)
|
Jun 22, 2026 |
|
Ipsen R&D chief on pipeline discipline, partnerships and 2026 milestones
|
Jun 12, 2026 |
|
Why MRD is becoming central to oncology drug development (Sponsored)
|
Jun 10, 2026 |
|
Behind the headlines of ASCO 2026
|
Jun 05, 2026 |
|
Mesutoclax points to possible shift in high-risk MDS and AML (Sponsored)
|
Jun 03, 2026 |
|
Boston, China and the future of biotech
|
May 29, 2026 |
|
Why direct-to-patient is the future of pharma access (Sponsored)
|
May 28, 2026 |
|
BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions
|
May 22, 2026 |
|
Designing an agentic, future‑ready tech roadmap for emerging pharma (Sponsored)
|
May 18, 2026 |
|
Health execs persevere in new policy landscape
|
May 15, 2026 |
|
Revisiting Pharma’s tariff reality
|
May 08, 2026 |
|
Setting a new standard in prefillable syringe systems (Sponsored)
|
May 07, 2026 |
|
Scaling theranostics through access, safety and trust (Sponsored)
|
May 04, 2026 |
|
A pivotal time for an RNA pioneer
|
May 01, 2026 |
|
Accelerating clinical trials with precision logistics (Sponsored)
|
Apr 27, 2026 |
|
Can Trump’s deal with the UK become a model for similar drug price agreements?
|
Apr 24, 2026 |
|
Biomarkers are reshaping oncology trial design (Sponsored)
|
Apr 21, 2026 |
|
AI brings precision to pharma content decisions (Sponsored)
|
Apr 20, 2026 |
|
Fixing failed spray-dried formulations faster (Sponsored)
|
Apr 20, 2026 |
|
Roivant’s CEO thinks China is a ‘red herring’
|
Apr 17, 2026 |
|
The top 10 pharma R&D budgets of 2025
|
Apr 10, 2026 |
|
An update on the pharma industry’s reshoring effort
|
Apr 03, 2026 |
|
Pulse check on Lilly's GLP-1 fortunes
|
Mar 27, 2026 |
|
Avoiding 11th hour surprises in clinical trials (Sponsored)
|
Mar 23, 2026 |
|
What Xaira is building after its $1B fundraise
|
Mar 20, 2026 |
|
Patent expirations push biopharma industry toward a tougher 2026
|
Mar 13, 2026 |
|
As AI evolves, the modern R&D lab is changing
|
Mar 06, 2026 |
|
How physiology powers biotech innovation (Sponsored)
|
Mar 02, 2026 |
|
Autoimmune CAR-T: Navigating the FDA’s new regulatory playbook
|
Feb 27, 2026 |
|
Inside the sterile fill capacity crunch (Sponsored)
|
Feb 23, 2026 |
|
Trump's tariff threats, measured by manufacturing
|
Feb 20, 2026 |
|
Why patient access must keep pace with drug innovation (Sponsored)
|
Feb 16, 2026 |
|
What were the biggest clinical trial flops of 2025?
|
Feb 13, 2026 |
|
Community oncology’s growing role in the future of cancer care (Sponsored)
|
Feb 09, 2026 |
|
The biggest potential drug launches of 2026
|
Feb 06, 2026 |
|
How Mirum is Advancing Rare Disease Care Through Strategic M&A (Sponsored)
|
Feb 03, 2026 |
|
Why human expertise still matters in AI-driven med comms (Sponsored)
|
Feb 02, 2026 |
|
Biopharma's rebound keeping pace so far
|
Jan 30, 2026 |
|
JPM26: Sunshine, AI and the deals that weren't
|
Jan 23, 2026 |
|
From approval to value: Why evidence storytelling now matters (Sponsored)
|
Jan 19, 2026 |
|
Drug approvals went from crawl to sprint in 2025
|
Jan 16, 2026 |
|
Putting patients first: from buzzword to business imperative (Sponsored)
|
Jan 12, 2026 |
|
Beyond the AI hype: How life sciences can turn agents into a competitive advantage (Sponsored)
|
Jan 12, 2026 |
|
China’s biotech moment goes global, Zai Lab exec says (Sponsored)
|
Jan 12, 2026 |
|
Biopharma CEOs assess the road ahead in 2026
|
Jan 09, 2026 |
|
A year in review and what 2026 holds for biopharma and healthcare
|
Dec 19, 2025 |
|
From data to decisions: how Walgreens is powering smarter pharma strategies (Sponsored)
|
Dec 08, 2025 |
|
The biopharma dealmaking landscape and what to expect in 2026
|
Dec 05, 2025 |
|
Advocacy, access and the future of cancer care take center stage in new Health Matters episode (Sponsored)
|
Dec 01, 2025 |
|
2025’s Fiercest Women in Life Sciences are changing the game
|
Nov 21, 2025 |
|
Bayer’s collaborative model: Breaking silos to accelerate impact (Sponsored)
|
Nov 17, 2025 |
|
Inside Foresight’s mission to redefine cancer monitoring (Sponsored)
|
Nov 17, 2025 |
|
Biopharma industry gathers momentum in Q3
|
Nov 14, 2025 |
|
PreCheck pulse check: What the industry is saying about FDA’s production initiative
|
Nov 07, 2025 |
|
How Pharma Can Build Trust and Reach Patients in Health Marketplaces (Sponsored)
|
Nov 03, 2025 |
|
Biotech Graveyard
|
Oct 31, 2025 |
|
Fierce 15: Where are they now?
|
Oct 24, 2025 |
|
Salesforce’s Mark Sullivan: AI and agentic systems will redefine life sciences (Sponsored)
|
Oct 20, 2025 |
|
Unpacking the FDA transparency push on CRLs
|
Oct 17, 2025 |
|
How Boehringer Ingelheim is buttressing its US business
|
Oct 10, 2025 |
|
AI is changing drug safety, but governance sets the guardrails (Sponsored)
|
Oct 06, 2025 |
|
A whirlwind week for pharma
|
Oct 03, 2025 |
|
Fierce Biotech's Fierce 15
|
Sep 26, 2025 |
|
Rebuilding trust in pharma in the age of misinformation
|
Sep 19, 2025 |
|
Schrödinger taps AI to speed drug discovery (Sponsored)
|
Sep 15, 2025 |
|
Inside the commercial growing pains of hemophilia gene therapies
|
Sep 12, 2025 |
|
A rare kind of leadership, 30 years in the making
|
Sep 05, 2025 |
|
Former FDA Chief Scott Gottlieb talks drug pricing, access and innovation (Sponsored)
|
Sep 01, 2025 |
|
Big Pharma bounces back in Q2
|
Aug 22, 2025 |
|
The battle of the obesity drug heavyweights
|
Aug 15, 2025 |
|
Is Trump’s MFN pricing order more bark than bite?
|
Aug 08, 2025 |
|
Rebuilding trust: compassionate communication and public health (Sponsored)
|
Aug 04, 2025 |
|
Untangling Sarepta’s gene therapy fallout and a growing trust deficit
|
Aug 01, 2025 |
|
Making sense of China’s R&D ascent
|
Jul 25, 2025 |
|
AI, mentorship and finding your voice in pharma marketing
|
Jul 18, 2025 |
|
Biopharma layoffs aren't letting up
|
Jul 11, 2025 |
|
Peter Pitts talks FDA direction, industry communication (Sponsored)
|
Jul 08, 2025 |
|
Teva’s CEO shares ‘Pivot to Growth’ progress
|
Jun 27, 2025 |
|
AbbVie, ADCs and the future of cancer care
|
Jun 20, 2025 |
|
Inside Fierce Medtech's Fierce 15
|
Jun 13, 2025 |
|
Inside ASCO 2025: Big data drops and a towering campaign
|
Jun 06, 2025 |
|
Forging the future of cell therapy: Bayer and BlueRock’s unique journey (Sponsored)
|
Jun 02, 2025 |
|
Science-led storytelling takes center stage in pharma communications (Sponsored)
|
Jun 02, 2025 |